BlackRock Health Sciences Trust
100 Bellevue Parkway
Wilmington, DE 19809
April 24, 2019
VIA EDGAR
Division of Investment Management
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | BlackRock Health Sciences Trust (the “Registrant”) |
Registration Statement on FormN-2 (File No. 333-230158)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Registrant hereby requests acceleration of the effective date of the above-referenced Registration Statement on FormN-2 so that it is declared effective on April 26, 2019, or as soon as practicable thereafter. BlackRock Investments, LLC, the principal distributor of the Registrant, hereby joins in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
If this request is granted, we respectfully request that we be notified by telephone at the time of effectiveness, and that such effectiveness also be confirmed in writing. Please call Stacey P. Ruiz of Willkie Farr & Gallagher LLP at (212)728-8037.
Very truly yours,
| BlackRock Health Sciences Trust | ||
| By: | /s/ Janey Ahn | |
| Name: Janey Ahn | ||
| Title: Secretary | ||
| BlackRock Investments, LLC | ||
| By: | /s/ Gregory Rosta | |
| Name: Gregory Rosta | ||
| Title: Director, Chief Compliance Officer | ||
